WAT
NYSEWaters Corporation
Price$365.34+46.32 (+14.52%)
2026-03-042026-06-05
News · 26 weeks88+17%
2025-12-142026-06-07
Mix2890d
- Other10(36%)
- SEC Filings8(29%)
- Insider6(21%)
- Analyst2(7%)
- Earnings2(7%)
Latest news
25 items- PRWaters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection DiagnosticsFDA 510(k)-cleared BD BACTEC™ FXI Culture System now available to U.S. market, enabling broader access to confident bloodstream infection diagnostics.Achieves a 3-hour faster time to detection (~15% reduction) versus the prior-generation system, per clinical study data, enabling earlier targeted sepsis prevention.Fully automated solution delivers an industry-leading 50% increase in vial loading and up to 960-vial per module capacity, maximizing walk-away time.MILFORD, Mass., June 3, 2026 /CNW/ -- Waters Corporation (NYSE:WAT) today announced that the BD BACTEC FXI Culture System has received U.S. Food and Drug Administration (FDA) 510(k) clearance. This clearance enables commercialization in
- ANALYSTWolfe Research resumed coverage on Waters with a new price targetWolfe Research resumed coverage of Waters with a rating of Outperform and set a new price target of $425.00
- PRWaters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics ResearchDelivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows.Identifies up to 40% more lipids by LC‑MS/MS than the leading alternative benchtop high‑resolution mass spectrometer, advancing lipidomics research and disease understanding.Sets a new benchmark for throughput in high-resolution spatial analysis with the DESI XS source, supporting higher-confidence studies of disease and treatment response.MILFORD, Mass., June 1, 2026 /CNW/ -- 74th ASMS Conference on Mass Spectrometry and Allied Topics—Waters Corporation (NYSE:WAT) today introduced the Waters Xevo™
- PRWaters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals.50% extended upper mass range and comprehensive suite of structural tools advance the development of next-generation biotherapeutics.Integrated MALDI XS and DESI XS imaging with high-resolution ion mobility enables direct visualization of molecules in tissue, improving understanding of how disease develops at the cellular level.MILFORD, Mass., June 1, 2026 /PRNewswire/ -- 74th ASMS Conference on Mass Spectrometry and Allied Topics— Waters Corporation (NYSE:WAT) today announced the launch of
- SECSEC Form SD filed by Waters CorporationSD - WATERS CORP /DE/ (0001000697) (Filer)
- SECSEC Form 8-K filed by Waters Corporation8-K - WATERS CORP /DE/ (0001000697) (Filer)
- PRWaters Corporation to Present at the Jefferies Global Healthcare ConferenceMILFORD, Mass., May 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3rd, 2026, at 10:30 AM Eastern Time. A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.About Waters CorporationWaters Corporation (NYSE:WAT) is a global leader in life sciences, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and se
- INSIDERSVP & Chief Financial Officer Chaubal Amol covered exercise/tax liability with 239 shares, decreasing direct ownership by 3% to 7,623 units (SEC Form 4) to satisfy withholding obligation4 - WATERS CORP /DE/ (0001000697) (Issuer)
- SECSEC Form 10-Q filed by Waters Corporation10-Q - WATERS CORP /DE/ (0001000697) (Filer)
- SECWaters Corporation filed SEC Form 8-K: Results of Operations and Financial Condition8-K - WATERS CORP /DE/ (0001000697) (Filer)
- PRWaters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial ResultsFirst Quarter 2026 HighlightsTotal reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and the acquired businesses.Organic revenue grew 13% as reported and 11% in constant currency, exceeding the high end of the constant currency growth guidance range by 200 basis points – led by high-single-digit instrument growth and mid-teens chemistry growth within the Analytical Sciences Division.The Biosciences and Diagnostic Solutions businesses generated $520 million of reported revenue since the closing of the acquisition – $40 million above guidance – driven by traction from commercial execution and o
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Waters CorporationSCHEDULE 13G/A - WATERS CORP /DE/ (0001000697) (Subject)
- PRWaters Corporation Schedules First Quarter 2026 Earnings Conference CallMILFORD, Mass., April 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least June 2, 2026, at midnight Eastern Time. About Waters CorporationWaters Corporation (NYSE:WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innova
- PRWaters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large MoleculesDelivers up to 4x faster chromatographic run times to accelerate decisions across discovery, development, and quality workflows.1,3Achieves 10x improvement in absolute molar mass and extended sizing, without compromising resolution or analytical throughput.2Reduces sample consumption by 30-50% and solvent use by approximately 40%.3MILFORD, Mass., April 14, 2026 /CNW/ -- Waters Corporation (NYSE: WAT) today announced the launch of the Waters omniDAWN™ Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt Technology Portfolio. Featuring 18 angles of detection, the omniDAWN Photometer is the first extended-range MALS detector for Ultra High Performance Liquid Chromatography (UHPLC)
- SECSEC Form DEFA14A filed by Waters CorporationDEFA14A - WATERS CORP /DE/ (0001000697) (Filer)
- SECSEC Form DEF 14A filed by Waters CorporationDEF 14A - WATERS CORP /DE/ (0001000697) (Filer)
- PRWaters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV AssayFDA-approved BD Onclarity™ HPV Assay is the most comprehensive screening tool for HPV in the U.S.1,4 with extended genotyping and end-to-end automated lab workflows.At-home self-collection reduces significant barriers for unscreened or under-screened individuals who make up approximately 60% of cervical cancer cases.3Waters is establishing partnerships to enable broader nationwide access to the Onclarity™ HPV Self-Collection Kit for patients and prescribers to reduce cervical cancer risk.MILFORD, Mass., April 8, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV Self-Collection Kit and approved the
- INSIDERSEC Form 4 filed by Bennett Jianqing4 - WATERS CORP /DE/ (0001000697) (Issuer)
- ANALYSTWaters upgraded by Evercore ISI with a new price targetEvercore ISI upgraded Waters from In-line to Outperform and set a new price target of $350.00
- INSIDERSEC Form 4 filed by Jiang Wei4 - WATERS CORP /DE/ (0001000697) (Issuer)
- INSIDERSEC Form 4 filed by Knight Heather4 - WATERS CORP /DE/ (0001000697) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Waters CorporationSCHEDULE 13G/A - WATERS CORP /DE/ (0001000697) (Subject)
- SECWaters Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement8-K - WATERS CORP /DE/ (0001000697) (Filer)
- INSIDERSEC Form 4 filed by Jiang Wei4 - WATERS CORP /DE/ (0001000697) (Issuer)
- PRWaters Prices Offering of Senior NotesMILFORD, Mass., March 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) (the "Company" or "Waters") today announced that it has priced an offering (the "Offering") of $3.5 billion aggregate principal amount of the following senior notes issued by its subsidiary, Augusta SpinCo Corporation ("Augusta"): $650 million aggregate principal amount of 4.321% Senior Notes due 2027 at the issue price of 100.000% of their principal amount;$600 million aggregate principal amount of 4.398% Senior Notes due 2029 at the issue price of 100.000% of their principal amount;$750 million aggregate principal amount of 4.656% Senior Notes due 2031 at the issue price of 100.000% of their principal amount;$750
WAT FAQ
7 questionsWhat does Waters Corporation do?
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based...Where does WAT stock trade?
Waters Corporation (WAT) is listed on NYSE.What sector and industry is WAT in?
Waters Corporation operates in the Industrials sector, Biotechnology: Laboratory Analytical Instruments industry.When did Waters Corporation go public?
Waters Corporation (WAT) completed its IPO in 1995.What are analysts saying about WAT?
Waters Corporation has had 8 recent analyst actions on file. The most recent action was from Wolfe Research: Outperform on 2026-06-02.What companies are similar to WAT?
Notable peers in the same industry include TMO (Thermo Fisher Scientific Inc), A (Agilent Technologies Inc.), PKI (PerkinElmer Inc.). Compare WAT side-by-side with any of them on Quantisnow.How can I track WAT on Quantisnow?
Quantisnow aggregates Waters Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow WAT to receive live email and push alerts on every new disclosure.